Cargando…
Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy
Human papillomavirus (HPV)-induced cervical cancer is a major health issue among women from the poorly/under-developed sectors of the world. It accounts for a high-mortality rate because of its late diagnosis and poor prognosis. Initial establishment and subsequent progression of this form of cancer...
Autores principales: | Pal, Asmita, Kundu, Rita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985034/ https://www.ncbi.nlm.nih.gov/pubmed/32038557 http://dx.doi.org/10.3389/fmicb.2019.03116 |
Ejemplares similares
-
Modulation of DNA methylation by human papillomavirus E6 and E7 oncoproteins in cervical cancer
por: Sen, Prakriti, et al.
Publicado: (2018) -
Performance of human papillomavirus E6/E7 mRNA assay for primary cervical cancer screening and triage: Population-based screening in China
por: Zhang, Jing, et al.
Publicado: (2022) -
Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker
por: Fontecha, Nerea, et al.
Publicado: (2016) -
High-Risk Human Papillomavirus Oncogenic E6/E7 mRNAs Splicing Regulation
por: Zheng, Yunji, et al.
Publicado: (2022) -
High Levels of Within-Host Variations of Human Papillomavirus 16 E1/E2 Genes in Invasive Cervical Cancer
por: Hirose, Yusuke, et al.
Publicado: (2020)